Nicholas A. Castello, Ph.D. - Publications

Affiliations: 
Neurobiology & Behavior University of California, Irvine, Irvine, CA 

14/19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Blurton-Jones M, Spencer B, Michael S, Castello NA, Agazaryan AA, Davis JL, Müller FJ, Loring JF, Masliah E, LaFerla FM. Correction: Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Research & Therapy. 15: 88. PMID 38523285 DOI: 10.1186/s13287-024-03702-7  0.7
2017 Czirr E, Castello NA, Mosher KI, Castellano JM, Hinkson IV, Lucin KM, Baeza-Raja B, Ryu JK, Li L, Farina SN, Belichenko NP, Longo FM, Akassoglou K, Britschgi M, Cirrito JR, et al. Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. The Journal of Experimental Medicine. PMID 28298456 DOI: 10.1084/Jem.20162011  0.409
2014 Myczek K, Yeung ST, Castello N, Baglietto-Vargas D, LaFerla FM. Hippocampal adaptive response following extensive neuronal loss in an inducible transgenic mouse model. Plos One. 9: e106009. PMID 25184527 DOI: 10.1371/Journal.Pone.0106009  0.716
2014 Lin AJ, Liu G, Castello NA, Yeh JJ, Rahimian R, Lee G, Tsay V, Durkin AJ, Choi B, LaFerla FM, Chen Z, Green KN, Tromberg BJ. Optical imaging in an Alzheimer's mouse model reveals amyloid-β-dependent vascular impairment. Neurophotonics. 1: 011005. PMID 25133200 DOI: 10.1117/1.Nph.1.1.011005  0.674
2014 Blurton-Jones M, Spencer B, Michael S, Castello NA, Agazaryan AA, Davis JL, Müller FJ, Loring JF, Masliah E, LaFerla FM. Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Research & Therapy. 5: 46. PMID 25022790 DOI: 10.1186/Scrt440  0.776
2014 Castello NA, Nguyen MH, Tran JD, Cheng D, Green KN, LaFerla FM. 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. Plos One. 9: e91453. PMID 24614170 DOI: 10.1371/Journal.Pone.0091453  0.733
2014 Chabrier MA, Cheng D, Castello NA, Green KN, LaFerla FM. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease. Neurobiology of Disease. 64: 107-17. PMID 24440055 DOI: 10.1016/J.Nbd.2014.01.007  0.723
2014 Lin AJ, Castello NA, Lee G, Green KN, Durkin AJ, Choi B, LaFerla F, Tromberg BJ. In vivo optical signatures of neuronal death in a mouse model of Alzheimer's disease. Lasers in Surgery and Medicine. 46: 27-33. PMID 24284732 DOI: 10.1002/Lsm.22206  0.704
2014 Medeiros R, Castello NA, Cheng D, Kitazawa M, Baglietto-Vargas D, Green KN, Esbenshade TA, Bitner RS, Decker MW, LaFerla FM. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles. The American Journal of Pathology. 184: 520-9. PMID 24269557 DOI: 10.1016/J.Ajpath.2013.10.010  0.75
2012 Castello NA, Green KN, LaFerla FM. Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology. Plos One. 7: e39566. PMID 22870188 DOI: 10.1371/Journal.Pone.0039566  0.73
2012 Castello N, Green K, LaFerla F. P3-037: Impact of genetic knockdown of brain-derived neurotrophic factor in 3xTg Alzheimer's mice Alzheimer's & Dementia. 8: P468-P468. DOI: 10.1016/J.Jalz.2012.05.1255  0.673
2010 Berchtold NC, Castello N, Cotman CW. Exercise and time-dependent benefits to learning and memory. Neuroscience. 167: 588-97. PMID 20219647 DOI: 10.1016/J.Neuroscience.2010.02.050  0.303
2010 Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller F, Loring JF, Poon WW, Green K, LaFerla FM. O1-04-01: Using neural stem cells to promote plasticity and improve cognition in transgenic AD mice Alzheimer's & Dementia. 6: S76-S76. DOI: 10.1016/J.Jalz.2010.05.225  0.76
2009 Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 106: 13594-9. PMID 19633196 DOI: 10.1073/Pnas.0901402106  0.726
Low-probability matches (unlikely to be authored by this person)
2019 Fang MY, Markmiller S, Vu AQ, Javaherian A, Dowdle WE, Jolivet P, Bushway PJ, Castello NA, Baral A, Chan MY, Linsley JW, Linsley D, Mercola M, Finkbeiner S, Lecuyer E, et al. Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD. Neuron. PMID 31272829 DOI: 10.1016/J.Neuron.2019.05.048  0.276
2008 Roozendaal B, Castello NA, Vedana G, Barsegyan A, McGaugh JL. Noradrenergic activation of the basolateral amygdala modulates consolidation of object recognition memory. Neurobiology of Learning and Memory. 90: 576-9. PMID 18657626 DOI: 10.1016/J.Nlm.2008.06.010  0.23
2021 Linsley JW, Shah K, Castello N, Chan M, Haddad D, Doric Z, Wang S, Leks W, Mancini J, Oza V, Javaherian A, Nakamura K, Kokel D, Finkbeiner S. Genetically encoded cell-death indicators (GEDI) to detect an early irreversible commitment to neurodegeneration. Nature Communications. 12: 5284. PMID 34489414 DOI: 10.1038/s41467-021-25549-9  0.126
2021 Linsley JW, Linsley DA, Lamstein J, Ryan G, Shah K, Castello NA, Oza V, Kalra J, Wang S, Tokuno Z, Javaherian A, Serre T, Finkbeiner S. Superhuman cell death detection with biomarker-optimized neural networks. Science Advances. 7: eabf8142. PMID 34878844 DOI: 10.1126/sciadv.abf8142  0.08
2001 Linares JL, Castello N, Colilles M. La thérapie familiale des psychoses comme processus de reconfirmation Cahiers Critiques De Therapie Familiale Et De Pratiques De Reseaux. 26: 61-81.  0.01
Hide low-probability matches.